Premium
Noninvasive prenatal diagnosis of cobalamin C (cblC) deficiency through target region sequencing of cell‐free DNA in maternal plasma
Author(s) -
Han Lianshu,
Chen Chao,
Guo Fengyu,
Ye Jun,
Peng Zhiyu,
Qiu Wenjuan,
Wang Yaoshen,
Li Wei,
Zhang Huiwen,
Liang Lili,
Wang Yu,
Wang Huanhuan,
Ji Xing,
Sun Jun,
Gu Xuefan
Publication year - 2020
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.5601
Subject(s) - compound heterozygosity , haplotype , prenatal diagnosis , proband , biology , genotype , genetics , cobalamin , fetus , pregnancy , allele , mutation , gene , endocrinology , vitamin b12
Objective This study aimed to validate the feasibility of haplotype‐based noninvasive prenatal diagnosis (NIPD) of cobalamin C (cblC) deficiency. Method This method includes three steps: First, targeted sequencing was performed on 21 families affected by cblC deficiency (including the couples and probands). Second, parental haplotypes linked with the pathogenic variant were determined using the genotypes of trios. Then, the fetal haplotypes were inferred through a parental haplotype assisted hidden Markov model (HMM). The NIPD results were confirmed by using the invasive procedures. Results Twenty‐one fetal genotypes were successfully inferred by NIPD including three compound heterozygotes with cblC deficiency, nine heterozygote carriers of cblC deficiency, and nine normal fetuses. The NIPD results were confirmed using the invasive procedures with 100% concordant rate. Conclusion This result has shown that haplotype‐based NIPD of cblC deficiency has high concordant rate and indicated potential clinical utility as a pregnancy diagnosis method for high‐risk carrier couples.